Sponsor:
Centessa Pharmaceuticals (UK) Limited
Code:
NCT06752668
Conditions
Narcolepsy Type 1
Narcolepsy Type 2
Idiopathic Hypersomnia
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
ORX750
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-15. This information was provided to ClinicalTrials.gov by Centessa Pharmaceuticals (UK) Limited on 2025-05-07.